Cardica Reports Fiscal 2016 Second Quarter Financial Results and Business Progress
Feb 04, 2016 21:05 pm UTC| Business
REDWOOD CITY, Calif., Feb. 04, 2016 -- Cardica, Inc. (Nasdaq:CRDC) today announced financial results for its fiscal second quarter ended December 31, 2015. Cardica’s management will hold a conference call at 4:30 p.m....
Lumentum Announces Fiscal Second Quarter 2016 Results
Feb 04, 2016 21:05 pm UTC| Business
Net Revenue of $218.3 million exceeded mid-point of guidanceNon-GAAP Operating margin of 9.0% exceeding mid-point of guidance; GAAP Operating margin of 2.8%Non-GAAP Net income per share of $0.31 exceeded upper-end of...
Intercept to Present at Upcoming Investor Conferences
Feb 04, 2016 21:05 pm UTC| Business
NEW YORK, Feb. 04, 2016 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic...
NETGEAR® Reports Fourth Quarter and Full Year 2015 Results
Feb 04, 2016 21:05 pm UTC| Business
Fourth quarter 2015 net revenue of $360.9 million, as compared to $353.2 million in the comparable prior year quarter, increase of 2.2%.Fourth quarter 2015 GAAP net income per diluted share of $0.66, as compared to $1.16...
Feb 04, 2016 21:05 pm UTC| Business
SANTA MONICA, Calif., Feb. 04, 2016 -- The board of directors of A-Mark Precious Metals, Inc. (NASDAQ:AMRK), a full-service precious metals trading company and an official distributor for all the major sovereign Mints,...
LinkedIn Announces Fourth Quarter and Full Year 2015 Results
Feb 04, 2016 21:05 pm UTC| Business
MOUNTAIN VIEW, Calif., Feb. 04, 2016 -- LinkedInCorporation (NYSE:LNKD), the world's largest professional network on the Internet, reported results for the fourth quarter and full year 2015. The transcript with prepared...
Five Prime Therapeutics to Present at the LEERINK Partners 5th Annual Global Healthcare Conference
Feb 04, 2016 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2016 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer...